A Cohort Study on Sleep Disorders During Pregnancy

Sponsor
Women's Hospital School Of Medicine Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05765149
Collaborator
(none)
1,000
1
11.5
87.2

Study Details

Study Description

Brief Summary

The goal of this observational study is to: 1) determine the prevalence of sleep disorders in pregnancy and the early postpartum; 2) identify factors associated with sleep disturbance during pregnancy and the early postpartum; 3) describe the progression of sleep quality and quantity as gestational age; 4) determine if sleep is associated with adverse perinatal outcomes. Participants were asked to wear a forehead sleep recorder for 4 consecutive days and to complete a sleep questionnaire at ten timepoints: at 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, and 9 months pregnant and at 1 month, 2 months and 3 months postpartum.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

There is a high incidence of sleep disturbances globally, especially among pregnant women. Long-term sleep disorders seriously affect the quality life of individuals, and it becomes undoubtedly an important public health problem. Studies have shown that sleep disorders during pregnancy can have short-term and long-term adverse effects on both mothers and their babies. In addition, sleep during pregnancy exhibits different characteristics at different stages. Most of the existing studies are based on the overall development trend to study sleep characteristics, ignoring potential individual differences. Based on the concept of precision medicine, this study intends to establish a cohort focusing on the sleep health of pregnant women, and carry out continuous home sleep monitoring of pregnant women from both subjective and objective perspectives. The aim of this study is, firstly, to explore the longitudinal change characteristics, potential classification and influencing factors of sleep during pregnancy; secondly, to analyze the differences in maternal and infant adverse outcomes among pregnant women with different sleep development trajectories. The final goal is to reveal the exposure window of maternal and infant adverse outcomes caused by sleep, thus improving the accuracy of outcome prediction, and promoting the development of accurate and personalized sleep management programs.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Sleep Trajectories Among Pregnant Women and Its Impact on Maternal and Infant Outcomes: a Prospective Cohort Study
Actual Study Start Date :
Feb 17, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Sleep Cohort

This is an observational study. We plan to recruit 1000 pregnant women during 10-13 weeks gestational age to build a sleep cohort. Their sleep changes during pregnancy will be recorded for identifying similar groups.

Other: No intervention
This is an observational study, no intervention will be implemented.

Outcome Measures

Primary Outcome Measures

  1. Preterm birth [delivery]

    Preterm birth refers to a body born before 37 weeks of gestation. It will be identified according to the medical history records.

  2. Caesarean section [delivery]

    Caesarean section refers to a baby delivered through an incision in the mother's abdomen. It will be identified according to the medical history records.

  3. Postpartum depression symptoms at 1 month after delivery [1 month after delivery]

    Postpartum depression symptoms at 1 month after delivery will be measured by the Edinburgh postpartum depression scale (EPDS).

  4. Postpartum depression symptoms at 2 months after delivery [2 months after delivery]

    Postpartum depression symptoms at 2 months after delivery will be measured by the Edinburgh postpartum depression scale (EPDS).

  5. Postpartum depression symptoms at 3 months after delivery [3 months after delivery]

    Postpartum depression symptoms at 3 months after delivery will be measured by the Edinburgh postpartum depression scale (EPDS).

Secondary Outcome Measures

  1. 1-minute Apgar score [1 minute after delivey]

    Apgar is a quick test performed on a baby at 1 and 5 minutes after birth. It will be identified according to the medical history records.

  2. 5-minute Apgar score [5 minutes after delivey]

    Apgar is a quick test performed on a baby at 1 and 5 minutes after birth. It will be identified according to the medical history records.

  3. Infant's length [delivey]

    It will be identified according to the medical history records.

  4. Infant's weight [delivey]

    It will be identified according to the medical history records.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Gestation age ≤ 13 weeks + 6 days

  2. 20 years old ≤ Age ≤ 40 years old

  3. Singleton pregnancy

  4. Give informed consent and able to participated

Exclusion Criteria:
  1. Unmarried, divorced or widowed

  2. Women who suffered severe physical or mental illness

  3. Women who suffered death, abortion, stillbirth or neonatal death during the study

  4. Women who are participating in other studies

  5. Other reasons

Contacts and Locations

Locations

Site City State Country Postal Code
1 Women's Hospital School of Medicine Zhejiang University Hangzhou Zhejiang China 310029

Sponsors and Collaborators

  • Women's Hospital School Of Medicine Zhejiang University

Investigators

  • Principal Investigator: Man Wang, Master, Women's Hospital School Of Medicine Zhejiang University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Women's Hospital School Of Medicine Zhejiang University
ClinicalTrials.gov Identifier:
NCT05765149
Other Study ID Numbers:
  • IRB-20220305-R
First Posted:
Mar 13, 2023
Last Update Posted:
Mar 13, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 13, 2023